Skip to main content

iRhythm Technologies to Participate in Upcoming Investor Conferences in September

SAN FRANCISCO, Aug. 21, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, announced today that the company will present at the following investor conferences in September:

  • Morgan Stanley 22nd Annual Global Healthcare Conference on Wednesday, September 4, at 3:20 pm Eastern Time
  • Wells Fargo 2024 Healthcare Conference on Thursday, September 5, at 8:45 am Eastern Time
  • Baird 2024 Global Healthcare Conference on Tuesday, September 10, at 2:00 pm Eastern time

Those interested in listening to the presentations may do so by accessing the live and archived webcast of the events on the “Events & Presentations” section of the company’s investor website at investors.irhythmtech.com.

About iRhythm Technologies, Inc.
iRhythm is a leading digital health care company that creates trusted solutions that detect, predict, and prevent disease. Combining wearable biosensors and cloud-based data analytics with powerful proprietary algorithms, iRhythm distills data from millions of heartbeats into clinically actionable information. Through a relentless focus on patient care, iRhythm’s vision is to deliver better data, better insights, and better health for all.

Investor Contact
Stephanie Zhadkevich
investors@irhythmtech.com

Media Contact
Kassandra Perry
irhythm@highwirepr.com


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  230.41
-4.28 (-1.82%)
AAPL  265.95
-6.46 (-2.37%)
AMD  237.89
-8.92 (-3.61%)
BAC  51.59
-1.02 (-1.95%)
GOOG  284.46
+7.48 (2.70%)
META  596.06
-13.40 (-2.20%)
MSFT  505.00
-5.18 (-1.02%)
NVDA  184.45
-5.72 (-3.01%)
ORCL  215.94
-6.91 (-3.10%)
TSLA  405.25
+0.90 (0.22%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.